519,064 articles
Daoism (Daoist school)
Daoism (道家) was a school of thought of China's Warring States period, grouped under one name by Han historians and politically influential in the early Western Han.
Daoism in Goryeo
Daoism in Goryeo (고려 도교) is the practice and state sponsorship of Daoism in Korea's Goryeo dynasty (918–1392), which favored Daoism most among Korea's states.
Daoist canon compilation bureaus
Daoist canon compilation bureaus were Song court enterprises that compiled the imperial Daoist canon, from Emperor Taizong's collation to the 4,565-juan Da Song Tiangong baozang completed in 1019.
Daoist establishment of Jin
The Daoist establishment of Jin (金朝道教教团) was the organized Daoism of the Jurchen Jin dynasty, with the Quanzhen, Dadao, and Taiyi schools founded in the mid-twelfth century.
Daolin Tang
Daolin Tang is a Professor of Surgery at UT Southwestern Medical Center in Dallas who directs the Center for DAMP Biology and studies ferroptosis, DAMPs, and pancreatic cancer.
Daomeng
Daomeng (道猛) was a Chinese Buddhist monk of the Liu Song dynasty who mastered the Tripitaka and became preeminent in the Chengshi lun, heading Xinghuang Temple from 465.
Daomin
Daomin (道旻, 1047–1114) was a Song-dynasty Chan Buddhist monk who succeeded to the dharma of Letan Yinggan, taught at Guanxi, and was the teacher of Zhenxie Qingliao.
Daonapa Patcharachai
Daonapa Patcharachai, earlier romanized as Daonapa Petampai or Petchermpai, is a Thai businesswoman who co-founded Muangthai Capital in 1992 and was named Thailand's wealthiest woman by Forbes in 2026.
Daonella
Daonella is an extinct genus of thin-shelled pelagic bivalves (Mojsisovics, 1874; type species Halobia lommeli) dominant in Middle Triassic to Early Carnian Tethyan seas, a biostratigraphic index fossil that evolved into Halobia and lived on soft, soupy seafloors.
Daoqi (Song Buddhist monk)
Daoqi (道齐), 929 to 997, was an early Song Buddhist monk of the Fayan school of Chan, a native of Hongzhou in modern Jiangxi with the secular surname Jin.
Daoqin
Daoqin (道钦), also written Faqin, was a Tang dynasty Chan Buddhist monk who founded Jingshan Monastery near Hangzhou and received the imperial title Guoyi Chanshi from Emperor Daizong in 768.
Daoshi
Daoshi (道世), also known by his style name Xuanyun, was an early Tang Chinese Vinaya monk who compiled the Fayuan zhulin, a 100-juan Buddhist encyclopedia completed in 668.
Daotong Investment & Aopumai Bio-manufacturing Fund
The Daotong Investment & Aopumai Bio-manufacturing Fund, registered as 上海奥创先导创业投资基金合伙企业, is a Shanghai venture fund for bio-manufacturing, launched in October 2025 with a target of RMB 1 billion.
Daou Data
Daou Data (다우데이타) is a South Korean company founded in 1992 that distributes software and hardware and runs VAN and electronic payment services, and is the top controlling company of the Daou Kiwoom Group.
Daou Technology
Daou Technology (다우기술) is a South Korean IT-services company founded in 1986, listed on the KOSPI since 1997, best known as the IT arm of the Daou Kiwoom group and the founder of Kiwoom Securities.
Daouda Karaboue
Daouda Karaboué, born 1975 in Abidjan, is a French-Ivorian retired handball goalkeeper; two Olympic golds (2008, 2012), world and European champion with France, Montpellier and Toulouse player, later goalkeeper coach.
Daowang
Daowang (道汪) was a Chinese Buddhist monk of the Liu Song dynasty, versed in the Nirvana Sutra, who led the sangha in Chengdu until his death in 466.
Daoxin
Daoxin (道信, 580–651), also known as Chan Master Dayi, was a Chinese Chan Buddhist monk counted as the Fourth Patriarch, between Sengcan and Hongren.
Daoxuan
Daoxuan (道宣) was a Tang dynasty Buddhist master, historian, and de facto founder of the Nanshan Vinaya school, whose commentaries shaped monastic ordination in China and Japan.
Daoy
Daoy, also written DAOY, is a continuous human cell line established in 1985 from a 4-year-old boy's cerebellar medulloblastoma, used as a standard laboratory model of the childhood brain tumor.
Daoyan
Daoyan (道颜, 1094–1164) was a Song-dynasty Chan Buddhist monk of the Linji school, best known as a dharma heir of Dahui Zonggao and abbot of Donglin monastery.
Daoying (Chan monk, d. 902)
Daoying (云居道膺), also romanized Yunju Daoyin, was a Chan Buddhist monk, a Dharma heir of Dongshan Liangjie who taught for over thirty years at Mount Yunju in Jiangxi.
Daoyue
Daoyue (道岳, 568–636) was a Chinese Buddhist monk of the Sui and early Tang dynasties, born in Luoyang, who specialized in the Abhidharmakośa and taught the young Xuanzang in Chang'an.
Daozhen
Daozhen (道震) is a Chan (Zen) monk traditionally dated 1079 to 1161, though no retrieved source independently documents him; he is associated with the Song Caodong revival.
Daozun
Daozun (道遵) is a figure placed in the Nanshan branch of the Tang Vinaya school, founded by Daoxuan, but his dates, teachers, monastery, and writings are all unverified.
DAP3
DAP3 (death associated protein 3, MRPS29/mS29) is a human GTP-binding protein of the mitochondrial ribosome small subunit, essential for mitochondrial translation, embryonic development, apoptosis signaling, and linked to Perrault syndrome and cancer.
Dapa-CKD trial
DAPA-CKD (Dapagliflozin And Prevention of Adverse Outcomes in Chronic Kidney Disease), NCT03036150: AstraZeneca-funded phase 3 trial of dapagliflozin 10 mg vs placebo in 4304 patients with proteinuric CKD stages 2–4, with or without type 2 diabetes; 39% relative risk reduction in the primary renal-cardiovascular composite endpoint.
DAPA-HF trial
DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure), NCT03036124: phase 3 trial of 4,744 patients showing dapagliflozin 10 mg daily reduced worsening heart failure or cardiovascular death (HR 0.74) in HFrEF with or without diabetes.
Dapaconazole
Dapaconazole, sold as Zilt, is an imidazole antifungal developed by Brazil's Biolab as a 2% topical cream for dermatophyte infections, reaching Phase 3 trials and performing non-inferior to ketoconazole and miconazole.
Dapagliflozin
Dapagliflozin, sold as Farxiga and Forxiga, is an SGLT2 inhibitor drug for type 2 diabetes, heart failure, and chronic kidney disease, first approved in 2014.